Skip to main content

Table 4 Overall survival (in months) of EOPC and older PDAC cohorts

From: Demographic, clinical, and pathological features of early onset pancreatic cancer patients

  Median survival (months)  
EOPC (N = 35) (≤50 years) PDAC (N = 334) (> 50 years) p value
Entire cohorta 12 (5–18.9 95%CI) 9 (7.8–10.2 95%CI) 0.168
Stage I-II 25 (12.9–37 95%CI) 13(10.5–15.5 95%CI) 0.307
Stage III 11 (3.9–18.1 95%CI) 8 (6.5–9.4 95%CI) 0.172
Stage IV 6 (3.2–8.8 95%CI) 6 (4.8–7.2 95%CI) 0.213
  1. aData missing for three EOPC and nine PDAC patients